KZIA
Kazia Therapeutics Ltd
8.80$
-5.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q3 24 | Q4 24 | Q3 25 | Q4 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.1 | 1.7 | 0.1 | 3.0 | 0.1 | 3.3 | 0.2 | 4.6 | 2.1 | 9.0 | 4.2 | 1.4 | 0.8 | 0.1 | 1.6 | 0.8 | 0.3 | 0.0 | 0.7 | 0.6 | 0.2 | -9.9 | 0.4 | 0.0 | 7.6 | – | 15 | 0.0 | – | – | -2.9 | – | 0.0 | – | 0.0 | 0.0 | 2.5 | 0.0 | 0.0 | – | |
| 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 5.8 | 0.0 | 0.0 | 0.0 | 9.9 | 0.0 | 0.0 | 0.0 | 9.8 | 0.0 | 0.0 | 0.0 | 9.9 | 0.0 | – | – | 9.9 | – | – | – | 2.9 | – | – | – | 2.9 | – | – | – | – | – | – | – | – | – | |
| 0.1 | 1.7 | 0.1 | 3.0 | 0.1 | 3.3 | -5.5 | 4.6 | 2.1 | 9.0 | -5.7 | 1.4 | 0.8 | 0.3 | -8.3 | 0.8 | 0.3 | 0.0 | -9.2 | 0.6 | 0.2 | -9.9 | 0.4 | 0.0 | 7.6 | – | 15 | 0.0 | – | – | -0.7 | -0.6 | 0.0 | – | 0.0 | 0.0 | 2.5 | 0.0 | 0.0 | – | |
| 1.7 | 3.0 | 3.3 | 5.0 | 2.4 | 3.7 | 4.9 | 4.9 | 3.1 | 5.0 | 6.3 | 4.7 | 2.5 | 1.0 | 5.1 | 3.7 | 1.4 | 0.1 | 2.8 | 4.2 | 2.6 | 0.0 | 5.3 | 2.9 | 5.8 | – | 12 | 11 | 4.6 | 4.7 | 9.2 | 9.4 | 3.1 | – | 6.2 | 4.3 | 13 | 4.3 | 3.0 | 4.9 | |
| 1.2 | 4.0 | 2.3 | 3.1 | 1.3 | 5.5 | 2.7 | 4.0 | 2.3 | 7.4 | 4.6 | 4.5 | 0.6 | 1.8 | 1.1 | 2.1 | 0.8 | 3.8 | 1.7 | 2.1 | 0.8 | – | 1.6 | 3.6 | 1.7 | – | 3.4 | 2.5 | 1.3 | 2.1 | 2.6 | 4.3 | 2.2 | – | 4.3 | 4.6 | 9.0 | 5.1 | – | – | |
| 2.5 | 9.8 | 5.0 | 6.9 | 4.3 | 16 | 8.6 | 8.8 | 5.4 | 19 | 11 | 1.2 | 4.1 | 0.0 | 8.2 | 6.9 | 2.6 | 0.1 | 5.2 | 6.3 | 3.6 | -10 | 6.9 | 6.4 | 8.8 | – | 15 | 13 | 5.9 | 6.9 | 25 | 14 | 3.5 | – | 11 | 8.9 | 22 | 9.4 | 6.5 | 13 | |
| -2.8 | -8.1 | -5.5 | -5.1 | -3.7 | -12 | -7.3 | -4.3 | -3.3 | -10 | -6.6 | -7.7 | -2.3 | -7.7 | -4.7 | -5.0 | -1.9 | -8.9 | -3.8 | -5.7 | -3.3 | 39 | -6.5 | -6.4 | 0.0 | – | 0.1 | -13 | -6.0 | -6.8 | -25 | -14 | -5.3 | – | -11 | -8.9 | -20 | -9.4 | -4.8 | -13 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | – | – | – | – | – | – | – | 4.4 | – | – | – | – | – | – | – | – | – | |
| -2.4 | -7.3 | -4.9 | -3.8 | -4.2 | -12 | -8.3 | -4.2 | -3.3 | -9.7 | -6.6 | 0.3 | -3.3 | -6.6 | -6.6 | -6.2 | -2.2 | -11 | -4.4 | -6.0 | -3.4 | 5.9 | -6.7 | -6.5 | -1.2 | – | -2.4 | -14 | -5.9 | -6.9 | -12 | -14 | -3.5 | – | -7.0 | -9.0 | -18 | -11 | -12 | -12 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.1 | -0.2 | -0.1 | -0.1 | 0.1 | 0.0 | -0.2 | -0.1 | 0.1 | -0.1 | -0.1 | -0.1 | 0.1 | -0.1 | -0.1 | -0.1 | 0.2 | -0.2 | -0.3 | -0.3 | 0.0 | 0.1 | -0.1 | -0.1 | 0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -1.6 | – | |
| -2.4 | -7.1 | -4.9 | -3.8 | -4.1 | -12 | -8.2 | -4.2 | -3.2 | -9.5 | -6.5 | 0.4 | -3.2 | -6.5 | -6.5 | -6.0 | -2.1 | -10 | -4.2 | -5.9 | -3.3 | 16 | -6.6 | -6.4 | -1.0 | – | -2.1 | -13 | -5.9 | -6.8 | -12 | -14 | -3.4 | – | -6.9 | -8.8 | -18 | -10 | -10.0 | -12 | |
| -2.6 | – | -5.2 | -4.8 | -3.5 | – | -7.0 | -3.7 | -2.9 | – | -5.7 | -6.7 | -2.1 | – | -4.1 | -4.5 | -1.6 | – | -3.2 | -5.1 | -3.0 | 39 | -6.0 | -5.9 | 0.4 | – | 0.8 | -13 | -5.5 | -6.4 | -11 | -13 | -4.8 | – | -9.6 | -7.9 | -19 | -8.4 | -4.8 | -13 |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.